Connect with us

Technology

The Galien Foundation Announces 2026 Prix Galien UK Award Candidates for “Best Biotechnology Product,” “Best Digital Health Solution,” “Best Medical Technology,” “Best Pharmaceutical Product,” “Best Public Sector Innovation” and “Best Health Equity Innovation”

Published

on

— Winners to be Announced on 11th June at the Prix Galien UK Awards Ceremony in London

LONDON, May 12, 2026 /PRNewswire/ — The Galien Foundation, the premier global institution dedicated to honouring innovators in life sciences, today announced the 2026 Prix Galien UK Award candidates for “Best Biotechnology Product,” “Best Digital Health Solution,” “Best Medical Technology,” “Best Pharmaceutical Product,” “Best Public Sector Innovation” and “Best Health Equity Innovation.” Winners will be selected by a committee of distinguished scientific leaders and announced during the Prix Galien UK Awards Ceremony, on 11th June at the Natural History Museum in London. To learn more and secure your ticket to the event, please visit our website here.

“Annually, the Prix Galien UK awards remind us that innovation in life sciences is not just about discovery, it’s about impact,” said Professor Sir Munir Pirmohamed, David Weatherall Chair of Medicine at the University of Liverpool and the NHS Chair of Pharmacogenetics, Chair of the Prix Galien UK Committee. “It is a privilege to return to this year’s Prix Galien UK Awards to recognise the latest cohort of innovators who embody the UK’s unwavering commitment to transforming scientific breakthroughs into better outcomes for patients, worldwide.”

The Prix Galien UK Awards Committee will be evaluating the innovation demonstrated throughout each product’s scientific development, clinical application, and utility. Further consideration is given to the insights it has advanced in biomedical science and the product’s tangible impact on human health.

“The Prix Galien stands as a global tribute to the power of human ingenuity in advancing health across the world,” said Bruno Cohen, Chairman of The Galien Foundation. “We look forward to continuing to honour those whose vision and dedication push the boundaries of medical progress as we approach the 2026 Prix Galien UK Awards.”

The 2026 Prix Galien UK Award Candidates are as follows:

Best Biotechnology Product (Candidates) 

Company

Product

Autolus Ltd

Aucatzyl

Kristal Biotech

Vyjuvek

Volition

Nu.Q® Vet Cancer Test

Best Digital Health Solution (Candidates) 

Company

Product

August International Limited

AI-Powered Real-time Telehealth Scheme

Evaxion

AI-Immunology™ platform

Evinova

Unified Trial Solution

Gulsine ltd.

A2P2 Platform

HARLEYDOC

HARLEYDOC APP

House of Possibility Limited
(TRADING AS RAPID TAPPING)

Rapid Tapping®

Otsuka Pharmaceuticals (UK) Ltd

Rejoyn

Perspectum

CoverScan

SökerData

SökerScan

Viscera Technologies Ltd

Quantico

Best Medical Technology (Candidates) 

Company

Product

MiniMed

MiniMed Go Smart MDI system

Novocure UK Limited

Optune Gio

Nyxoah SA

Genio

Smith & Nephew Medical Ltd.

RENASYS EDGE

THERMOTRAUMAPORT LTD

THERMOTRAUMAPORT

U-test diagnostics

U-test @ Home

Best Pharmaceutical Product (Candidates) 

Company

Product

AbbVie UK

Elahere®

Aventis Pharma (SANOFI)

TZIELD

Blueprint Medicines, a Sanofi company

Gilead Sciences Ltd

Sunlenca/Yeytuo

Incyte Biosciences UK Ltd

Opzelura® (ruxolitinib) 15 mg/g cream

Novartis Pharmaceuticals UK

Iptacopan▼

PhytoQuest Limited

Q-actin®

Servier Laboratories Ltd

Voranigo▼

Shionogi

Fetcroja

ViiV Healthcare

Apretude

Best Public Sector Innovation (Candidates) 

Company

Product

BioDundee

BioDundee’s Life Sciences and Healthcare Innovation Ecosystem

University College London Centre for Digital
Public Health in Emergencies (UCL dPHE)

Digital platform for vector-borne diseases (VBD) surveillance and early warning in Brazil and Madeira

University of Glasgow

Intensive low-calorie weight management programme to induce type 2 diabetes remission

University of Liverpool

Liverpool’s COVID-19 Trio: ISARIC (clinical characterisation), SMART (testing) and AGILE (trials)

University of Liverpool and Liverpool University
Hospitals NHS Foundation Trust

LDIR Tech

Well Cool Clothing Ltd

Well Cool Patient Wear

Best Health Equity Innovation (Candidates) 

Company

Product

Agios Pharmaceuticals, Inc.

Clinical Trials Designed with Patients, for Patients: RISE UP Sickle Cell Disease Clinical Program

Eli Lilly as the Sponsor in collaboration with 
North West e-Health, Health Innovation
Manchester and the University of Manchester

An open-label, pragmatic clinical trial in a UK real world setting in people living with obesity

HARLEY of LONDON

Harley Wellness Dollar Empowering Community Health, Wellness and Lifestyle

National Institute for Health and Care
Excellence (NICE)

NICE technology appraisal guidance (TA1044) for exagamglogene autotemcel (exa-cel) for
treating severe sickle cell disease in people 12 years and over. TA1044

Nuffield Department of Primary Care
Health Sciences University of Oxford

Centre for Research Equity through pharmacy, communities and healthcare

ProFactor Pharma

Affordable recombinant Factor VIII

Quercis Pharma AG

Kinisoquin™

Sisters of Support CIC

Sisters of Support

The Drug Discovery Unit, University of Dundee

Drug Discovery for Neglected Infectious Diseases

University of Glasgow

Enabling equitable access to lifesaving rabies post-exposure prophylaxis

The Prix Galien Awards were established in 1970 and launched in the UK in 1990 and have been awarded to 62 products since its inception. Winners are selected every year by the Prix Galien UK Awards Committee, which comprises 12 experts in the field, and includes a number of the UK’s leading luminaries in healthcare. The distinguished panel is guided by the conviction that acknowledging research-driven innovation is key to the improvement of healthcare in the UK and human health, globally.

During the ceremony, the 2026 Prix Galien UK Lifetime Achievement Award will be bestowed upon Dame Kate Bingham, Former Chair of the UK Government’s Vaccine Taskforce. The keynote address will be delivered by Dr John-Arne Røttingen, MD, PhD, CEO, Wellcome; Committee Member, Prix Galien Bridges.

Prix Galien UK Awards Committee 2026

Professor Sir Munir PIRMOHAMED
David Weatherall Chair of Medicine, University of Liverpool, NHS Chair of Pharmacogenetics
Committee Chair

Professor Jane ADAM
Honorary Professor, University of Exeter, Consultant Radiologist, St George’s Hospital London and former Chair Technology appraisal committee, NICE

Professor Bruce CAMPBELL
Past Chair NICE Interventional Procedures and Medical Technologies Advisory Committees; Honorary Vascular Consultant and Professor, Exeter

Alison CAVE, PhD
Chief Safety Officer, Medicines and Healthcare products Regulatory Agency (MHRA)

Professor Jesse DAWSON
Professor of Stroke Medicine at School of Cardiovascular and Metabolic Health in the College of Medical, Veterinary and Life Sciences at the University of Glasgow; Consultant Physician in the Queen Elizabeth University Hospital, Glasgow

Doctor Stephanie KUKU
Chief Knowledge Officer – Conceivable Life Sciences, Senior Consultant – Hardian Health, Board Trustee – The Kings Fund, Honorary Senior Research Fellow, UCL

Professor Sudhesh KUMAR, OBE
Vice President (Health), University of Warwick and President of Association of Innovation, Research and Technology Organisations, UK (AIRTO)

Professor Andrew MORRIS, CBE
Director, Health Data Research UK & Professor of Medicine and Vice Principal Data Science, University of Edinburgh

Professor Sharon PEACOCK, CBE
Master of Churchill College Cambridge

Professor Duncan RICHARDS
Professor of Clinical Therapeutics, University of Oxford

Doctor Lauren WALKER
Professor of Clinical Pharmacology & Therapeutics, University of Liverpool

Professor Dame Moira WHYTE
Sir John Crofton Professor of Respiratory Medicine, University of Edinburgh

About The Galien Foundation 
The Galien Foundation fosters, recognizes, and rewards excellence in scientific innovation to improve human health. Its vision is to serve as a catalyst for the development of the next generation of treatments and technologies that will transform medical practice and save lives. Established in Paris in 1970 by Roland Mehl in honor of Galen, the father of medical science and modern pharmacology, the Prix Galien is widely regarded as the equivalent of the Nobel Prize in biopharmaceutical research.

Today, the Prix Galien operates in 16 countries across Africa, Europe, the United States and the UK. Expansion is currently underway in South Korea, Japan, Singapore, and Australia.

In 2025, the Foundation launched the inaugural Prix Galien Bridges Forum and Awards Ceremony at the Nobel Forum in Stockholm, spanning Northern and Southern Europe, Israel, and the Middle East, and the first-ever Patient Summit for Prix Galien USA, reinforcing its commitment to science without borders.

The Nobel Prize and the Prix Galien share a common birthplace in Paris, where Alfred Nobel signed his last will and testament in 1895. However, while the Nobel Prize in Physiology or Medicine recognises up to three individuals for specific discoveries, the Prix Galien honours the collaborative spirit and multidisciplinary progress that define modern biopharmaceutical innovation.

For more information, visit www.galienfoundation.org.

See the UK Hall of Fame: https://infogram.com/prix-galien-uk-since-1990-1hnp27e0qqyzn4g.

Follow the Foundation on social media:
https://www.facebook.com/GalienFoundation/ 
https://twitter.com/GalienFdn
https://www.linkedin.com/company/the-galien-foundation/

Media Contact (UK):
Julian Tyndale-Biscoe
Finn Partners
Julian.Tyndale-biscoe@finnpartners.com
+44 20 3217 7060

Media Contact (Global):
Kara Bradley
Finn Partners
Kara.Bradley@finnpartners.com
646-213-7243

Logo – https://mma.prnewswire.com/media/2592709/The_Galien_Foundation_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/the-galien-foundation-announces-2026-prix-galien-uk-award-candidates-for-best-biotechnology-product-best-digital-health-solution-best-medical-technology-best-pharmaceutical-product-best-public-sector-innovation-and–302768995.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

MediSun Energy and Guangdong Beijing Enterprises Shixi Technology Announce Global Distributorship for Advanced SBR-AGS Municipal Wastewater Solutions, Securing Exclusive Distribution in Malaysia and Saudi Arabia

Published

on

By

GUANGZHOU, China, Aug. 6, 2026 /PRNewswire/ — MediSun Planet Pte Ltd (“MediSun Energy”), a leader in integrated water technology and advanced circular solutions, today announced a landmark global distributorship with Guangdong Beijing Enterprises Shixi Technology Co., Ltd. Under this strategic agreement, MediSun Energy secures global distribution rights for the company’s flagship Sequential Batch Reactor – Aerobic Granular Sludge (SBR-AGS) municipal wastewater technology, including exclusive distribution rights across Malaysia and comprehensive strategic cooperation in the Kingdom of Saudi Arabia.

By fusing MediSun Energy’s cutting-edge plant design and core systems engineering with the formidable operational heritage of Guangdong Beijing Enterprises Shixi Technology—one of the top three water environmental enterprises in the world—the two organizations are spearheading a monumental shift in environmental infrastructure. Working hand-in-hand on joint plant design, MediSun Energy will provide comprehensive in-market engineering support to localize plant designs, ensuring full compliance with regional environmental standards, local civil constraints, and municipal utility interfaces.

By integrating high-efficiency SBR-AGS biological processes into standardized, modular engineering formats, the combined solution solves the most pressing bottlenecks facing modern utilities: severe urban land scarcity, long civil construction timelines, high energy demands, and strict nutrient discharge limits.

Key technical highlights of the SBR-AGS modular solution lineup include:

Biomimetic Honeycomb Modular Systems: Engineered for compact and permanent municipal needs (5,000 m³/d module scale), utilizing a prefabricated hexagonal “beehive” weathering steel structure that enables rapid on-site assembly within 15–35 days, while achieving total nitrogen removal up to 85% and biological phosphorus removal exceeding 90%.Large-Scale Modular Wastewater Treatment Complexes: Designed for major municipal infrastructure handling up to 50,000 m³/d per unit, seamlessly integrating biochemical treatment, magnetic flocculation, and UV disinfection into an aesthetic, low-profile footprint. Operating at an ultra-compact 0.2 m²/m³, it delivers 30–50% energy savings and 10–20% capital cost reductions with a deployment cycle of just 60–90 days.

Joseph Chua, President & Co-Founder of MediSun Planet Pte Ltd, stated: “Municipalities across Southeast Asia, the Middle East, and globally are seeking immediate, scalable solutions to expand wastewater treatment capacity while meeting aggressive decarbonization and footprint goals. Traditional concrete construction can no longer keep pace with rapid urbanization. By leading the engineering and plant design alongside Guangdong Beijing Enterprises Shixi Technology—and leveraging their massive plant management expertise as one of the world’s top three water environmental leaders—we are delivering a game-changing, plug-and-play pathway that turns years of civil construction into weeks of modular deployment across key markets like Malaysia and Saudi Arabia.”

Junfang Zhou (周俊芳), General Manager of Guangdong Beijing Enterprises Shixi Technology Co., Ltd., added: “Guangdong Beijing Enterprises Shixi Technology Co., Ltd. has consistently set global benchmarks in biological wastewater treatment and large-scale plant operations. Partnering closely with MediSun Energy allows us to combine our deep operational heritage, world-class SBR-AGS technological legacy, and plant management experience with MediSun’s agile plant design, engineering strength, and expanding global market presence. Together, we are redefining modern water infrastructure with low-carbon, highly efficient modular plants engineered for the future.”

The agreement accelerates the commercial rollout of decentralized municipal wastewater infrastructure, providing utilities and industrial parks worldwide with a proven, rapidly deployable pathway toward low-carbon, space-efficient wastewater management.

About MediSun Energy
MediSun Energy is a Singapore-headquartered water infrastructure company that delivers water as a product: factory-built, modular plants deployed in weeks and run by AI. Its platform spans clean water, brine recovery, compact sewage treatment and portable water systems, serving government and industrial programmes across the Gulf and Southeast Asia.

About Guangdong Beijing Enterprises Shixi Technology Co., Ltd.
BE SHIXI TECH is a leading high-tech water enterprise specializing in water supply, advanced biological wastewater treatment, reclaimed water, modular product innovation, and high-efficiency equipment manufacturing. With end-to-end capabilities spanning R&D, design, manufacturing, delivery, and rapid response, the company delivers low-carbon, integrated turnkey solutions, customized process packages, and full-station equipment integration for municipal and industrial applications worldwide — meeting comprehensive project needs in performance, efficiency, and sustainability.

View original content to download multimedia:https://www.prnewswire.com/news-releases/medisun-energy-and-guangdong-beijing-enterprises-shixi-technology-announce-global-distributorship-for-advanced-sbr-ags-municipal-wastewater-solutions-securing-exclusive-distribution-in-malaysia-and-saudi-arabia-302844559.html

SOURCE MEDISUN PLANET PTE. LTD.

Continue Reading

Technology

iSearchSolution Explores the Impact of AI on Modern SEO Services

Published

on

By

NEW DELHI, Aug. 6, 2026 /PRNewswire/ — As AI has reshaped almost every aspect of doing business, especially in Digital marketing, it has created the urgency to reframe SEO approaches. It raises the demand for enhanced search visibility, pushing brands toward smarter, intent-led SEO strategies.

To understand the core shift, the iSearchSolution in-house team conducted 50+ queries across ChatGPT, Claude AI, Perplexity, and Google Gemini. The queries were targeted to understand how ChatGPT cites company names and how Gemini produces overviews. According to the team, the New SEO algorithms no longer chase rankings; they look for recognition. 

Key findings of the research:

Google’s overview provides a 45- to 50-word summary of the query, smartly compiled from multiple sources. Technical SEO must be strong and clean. If a web page takes more than one second, one can reduce conversions by up to 7%.Technical SEO techniques must align with one’s project goals.Content should be published weekly.Domain authority matters a lot.Don’t mindlessly insert a keyword; it must be focused on search intent and people’s queries. 

As a leading SEO company in India, they focus not just on SERP positions but on building a digital network to create positive signals. They are not empowering brands for one, but for 50+ LLMs. Their AI SEO services are designed to be consistent with structural changes in information: how it appears, interacts with, and is ultimately trusted.

“I have observed the digital marketing industry reinvent itself completely four or five times. Each time, the agencies that survived were not those that found the new shortcut but those that understood the new logic and implemented it strategically. Our research confirmed that something the broader industry is now recognizing: the question has changed. We are no longer fighting for ‘how do I rank? It is about ‘Is my brand recognized as the right answer?’ Those require fundamentally different strategies,” said Deelip Kumar, Founder and CEO of iSearchSolution.

Kumar added a note of urgency for companies that have delayed addressing this shift. “Every month, a competitor earns AI citations, and you do not; their recognition signal in those systems compounds. Over time, this gap becomes harder to close, even with increased marketing spend.”

The digital ecosystem is no longer a library of links; it is a cognitive interface where information becomes instant insight. Platforms like ChatGPT serve 800 million active users and handle more than 2 billion queries daily. So, content creation needs to be more focused and planned because the goal is no longer just to be found, but to be recognized as a trusted leader.

Media Contact:
info@isearchsolution.com
+91-9871312382

About iSearchSolution

Founded in 2010, iSearchSolution is a 360-degree digital marketing agency that offers AI-driven search engine solutions. The company understands that the search era has shifted from keywords to conversational queries, and has updated its services accordingly. Apart from content marketing, pay-per-click advertising also works for Answer Engine Optimization, Generative Engine Optimization, and AI SEO services.

Over the past 15 years, the agency has delivered organic growth programs for clients across the healthcare, automotive, e-commerce, and logistics sectors in India and internationally.

For more details, visit https://www.isearchsolution.com/

 

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/isearchsolution-explores-the-impact-of-ai-on-modern-seo-services-302843733.html

Continue Reading

Technology

IFI TECHSOLUTIONS ACHIEVES MICROSOFT AZURE CLOUD SECURITY SPECIALIZATION

Published

on

By

Recognition underscores enterprise-scale Azure security and governance capabilities for modern cloud environments

MUMBAI, India, Aug. 6, 2026 /PRNewswire/ — IFI Techsolutions Limited (“IFI Techsolutions”), a global cloud solutions and managed services provider, today announced that it has achieved the Microsoft Azure Cloud Security specialization, demonstrating its expertise in helping organizations secure, govern, and manage cloud environments on Microsoft Azure.

Awarded to Microsoft partners that meet rigorous standards for technical expertise, customer success, and delivery excellence, the specialization validates the company’s ability to design and implement security-first Azure environments aligned with enterprise and regulatory requirements.

The recognition reflects proven capabilities in identity and access management, threat protection, security monitoring, and cloud governance, enabling organizations worldwide to strengthen cyber resilience, reduce risk exposure, and establish secure foundations for digital transformation.

The company has demonstrated this approach across diverse enterprise environments. For a large real estate enterprise, IFI Techsolutions helped restore a customer-facing digital platform following a security incident through breach assessment, remediation, and continuous monitoring. In the financial services sector, the company deployed a centralized security operations framework powered by Microsoft Sentinel, enabling real-time monitoring, improved threat detection, automated response workflows, and stronger incident governance. Together, these engagements demonstrate IFI Tech’s ability to manage complex security operations at scale.

Puneet Bajaj, CTO, IFI Techsolutions, said:

“As enterprises continue to accelerate cloud adoption, security and governance must be foundational to every cloud strategy. This specialization validates our ability to help organizations establish secure Azure landing zones, implement Zero Trust controls, strengthen identity governance, and modernize security operations through Microsoft-native platforms.”

IFI Techsolutions remains focused on advancing its Azure security capabilities and helping enterprises build resilient, governed, and future-ready digital platforms.

About IFI Techsolutions Limited

Founded in 2013, IFI Techsolutions Limited is a global cloud solutions and managed services company headquartered in India, with operations across the United States, United Kingdom, Australia, Singapore, Canada, the UAE, New-Zealand, and Ireland. The company delivers cloud transformation, AI-led analytics, cybersecurity, and modern workplace solutions, enabling enterprises to accelerate digital innovation and business agility. With 680+ cloud projects delivered for more than 370 clients globally, 150+ Microsoft certifications, and over 120,000 consulting hours across 40+ countries, IFI Techsolutions combines deep technology expertise with a customer-centric approach to deliver secure, scalable, and outcome-driven digital transformation, with responsible AI, automation, and governance.

Media Contact
IFI Techsolutions Limited
Email: pr@ifi.tech 
Website: https://ifi.tech 

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/ifi-techsolutions-achieves-microsoft-azure-cloud-security-specialization-302843995.html

Continue Reading

Trending